calendar
7,685 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 259 earnings · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
7,685 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 259 earnings · 2 approval · 1 adcom
Sponsor: University Hospital, Rouen. Phase: PHASE4. Conditions: Bullous Pemphigoid
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Primary or Secondary Immune Deficiency Including Immunosuppressive Therapy, Chemotherapy, HIV Infection
Sponsor: Azienda Unità Sanitaria Locale (A.U.S.L.) Ferrara, Italy. Phase: . Conditions: Periodontal Diseases, Periodontitis
Sponsor: Afimmune. Phase: PHASE2. Conditions: Sickle Cell Disease
Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Stress Disorders, Post-Traumatic
Sponsor: University of Alberta. Phase: NA. Conditions: Spasticity, Muscle
Sponsor: Antengene Biologics Limited. Phase: PHASE1. Conditions: Advanced/Metastatic Solid Tumors
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild. Phase: . Conditions: Meningioma
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Multiple Myeloma
Sponsor: Neuro Event Labs Inc.. Phase: . Conditions: Epilepsy
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Acute Heart Failure (AHF)
Sponsor: Guy's and St Thomas' NHS Foundation Trust. Phase: NA. Conditions: Cardiac Surgery, Infection, Soft Tissue, Wound Healing, Swabs, Self Management
Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Aging
Sponsor: University Hospital Bispebjerg and Frederiksberg. Phase: PHASE4. Conditions: Bipolar II Disorder
Sponsor: Ottawa Hospital Research Institute. Phase: PHASE4. Conditions: Atrial Fibrillation
Sponsor: VA Office of Research and Development. Phase: NA. Conditions: High-Grade Early-Stage Bladder Cancer
Sponsor: Sri Ramachandra Institute of Higher Education and Research. Phase: . Conditions: Personality Type, Leadership Style, Training Status
Sponsor: Mondelēz International, Inc.. Phase: NA. Conditions: Gastrointestinal Tolerance, Healthy Population
Sponsor: AO Innovation Translation Center. Phase: . Conditions: Temporomandibular Joint Disorders
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic Prostate Neuroendocrine Carcinoma, Metastatic Prostate Small Cell Neuroendocrine Carcinoma, Stage IVB Prostate Cancer AJCC v8
Sponsor: Hôpital le Vinatier. Phase: . Conditions: Cocaine Use Disorder
Sponsor: NeuroRx, Inc.. Phase: . Conditions: Bipolar Depression, Bipolar Affective Disorder
Sponsor: I.R.C.C.S. Fondazione Santa Lucia. Phase: NA. Conditions: Spinal Cord Injury
Sponsor: Assiut University. Phase: . Conditions: Inflammatory Bowel Diseases Weight Changes
Sponsor: Sydney Local Health District. Phase: NA. Conditions: Class III Malocclusion, Underbite
Sponsor: Yonsei University. Phase: PHASE2. Conditions: Neoplasms of Connective and Soft Tissue With an Unspecified Anatomical Site
Sponsor: Bristol-Myers Squibb. Phase: . Conditions: Muscle-invasive Urothelial Carcinoma
Sponsor: University of Thessaly. Phase: NA. Conditions: Obesity & Overweight
Sponsor: Southeast University, China. Phase: . Conditions: Acute Respiratory Distress Syndrome
Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Early Colorectal Cancer, Non-curative Endoscopic Resection
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Eosinophilia, Hypereosinophilic Syndrome
Sponsor: Outcome Referrals, Inc.. Phase: . Conditions: Adolescent Well-Being, Mental Disorders, Severe
Sponsor: Alexandria University. Phase: NA. Conditions: Maxillofacial Reconstruction
Sponsor: Beijing Kanova Biopharmaceutical Co., LTD. Phase: PHASE1. Conditions: Asthma
Sponsor: University of Louisville. Phase: NA. Conditions: Parkinson Disease
Sponsor: Dokuz Eylul University. Phase: NA. Conditions: Liver Transplant Disorder
Sponsor: National Institute of Environmental Health Sciences (NIEHS). Phase: . Conditions: Myositis, Dermatomyositis, Polymyositis, Juvenile Dermatomyositis, Juvenile Polymyositis
Sponsor: Prime Gene Therapeutics Co., Ltd.. Phase: PHASE1. Conditions: Lichen Simplex Chronicus
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: NA. Conditions: Thymus Neoplasms
Sponsor: Ente Ospedaliero Cantonale, Bellinzona. Phase: . Conditions: Multiple Sclerosis
Sponsor: Steno Diabetes Center Copenhagen. Phase: . Conditions: Peripheral Diabetic Neuropathy, Cardiovascular Autonomic Neuropathy, Cognitive Impairment, Diabetes Type 2
Sponsor: LMU Klinikum. Phase: NA. Conditions: Heart Failure Attributable to Severe Tricuspid Regurgitation
Sponsor: Madrigal Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Heterozygous Familial Hypercholesterolemia
Sponsor: Gazi University. Phase: NA. Conditions: Multiple Sclerosis
Sponsor: Beijing Anzhen Hospital. Phase: . Conditions: Heart Failure
Sponsor: Ming Yang. Phase: . Conditions: Non-Small Cell Lung Cancer, Brain Metastases
Sponsor: University of Minnesota. Phase: NA. Conditions: Chronic Tic Disorder
Sponsor: Yonsei University. Phase: NA. Conditions: Adult, Laryngeal Masks, Remimazolam, Remifentanil
Sponsor: Hvidovre University Hospital. Phase: NA. Conditions: Cervical Cancer Screening, HPV, Thermal Ablation
Sponsor: Chun Lun Hsu. Phase: NA. Conditions: Moral Injury, Perceived Stress, Resilience, Ethics Education